Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
03 2021
Historique:
received: 08 07 2020
accepted: 07 12 2020
pubmed: 8 1 2021
medline: 10 9 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

To study whether serum galectin-3 and other biomarkers of inflammation predict coronary heart disease (CHD) in subjects with long-standing childhood-onset type 1 diabetes. A population-based nationwide cohort of 299 subjects with type 1 diabetes diagnosed in Norway at <15 years of age during 1973-1982 was examined in 2002-2003 at a mean age of 33 years (range 21-44), with mean diabetes duration of 24 years (range 19-30). Subjects were followed through 31 December 2017 for their first CHD event registered by a hospitalization or cause of death using nationwide registries. Stored serum samples were available for 296 subjects and analyzed for interleukin-6 (IL-6), IL-6 receptor, IL-18, hs-CRP, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), galectin-3, and high-sensitivity troponin T. Adjusted hazard ratios (aHRs) for CHD per SD increase in biomarker were estimated using Cox regression. Of 295 subjects, 40 (13.6%) had a documented CHD event during a mean follow-up of 14.4 years (range 0.5-16). IL-6 (aHR 1.32 [95% CI 1.07-1.63]), galectin-3 (aHR 1.44 [95% CI 1.09-1.80]), and TIMP-1 (aHR 1.37 [95% CI 1.04-1.81]) were significant predictors of CHD after adjustment for conventional risk factors. Galectin-3 was significantly associated with future CHD in subjects with type 1 diabetes, and if the results are replicated in larger studies, it may aid in prediction together with conventional risk factors for CHD.

Identifiants

pubmed: 33408220
pii: dc20-1712
doi: 10.2337/dc20-1712
pmc: PMC7896257
doi:

Substances chimiques

Galectin 3 0
Tissue Inhibitor of Metalloproteinase-1 0

Banques de données

figshare
['10.2337/figshare.13348088']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

810-816

Informations de copyright

© 2021 by the American Diabetes Association.

Références

Immunol Rev. 2009 Jul;230(1):160-71
pubmed: 19594635
J Intern Med. 2012 Jul;272(1):55-64
pubmed: 22026577
Glycobiology. 2013 Jun;23(6):654-63
pubmed: 23426722
J Clin Med. 2020 Apr 13;9(4):
pubmed: 32294902
Atherosclerosis. 2015 Jan;238(1):33-7
pubmed: 25437887
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2045-51
pubmed: 22895665
Diabetes. 2013 Jun;62(6):1932-44
pubmed: 23349493
Circulation. 2016 Mar 15;133(11):1058-66
pubmed: 26888765
Hypertension. 2015 Oct;66(4):767-75
pubmed: 26238446
Lancet. 2010 Jan 9;375(9709):132-40
pubmed: 20031199
Diabetes. 2005 Dec;54 Suppl 2:S114-24
pubmed: 16306329
Circ Heart Fail. 2013 Jan;6(1):107-17
pubmed: 23230309
Scand J Public Health. 2020 Feb;48(1):49-55
pubmed: 31288711
Pediatr Diabetes. 2006 Oct;7(5):239-46
pubmed: 17054444
Diabet Med. 2017 Jan;34(1):56-63
pubmed: 26996105
Cardiovasc Diabetol. 2017 Oct 25;16(1):139
pubmed: 29070037
N Engl J Med. 2017 Apr 13;376(15):1407-1418
pubmed: 28402770
Immunol Rev. 2018 Jan;281(1):138-153
pubmed: 29247988
Eur J Heart Fail. 2013 Oct;15(10):1095-101
pubmed: 23650131
Circulation. 2000 Apr 18;101(15):1767-72
pubmed: 10769275
Mech Ageing Dev. 2007 Jan;128(1):83-91
pubmed: 17118425
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
Int J Cardiol. 2015 Mar 1;182:168-70
pubmed: 25577755
N Engl J Med. 2005 Apr 14;352(15):1611-3
pubmed: 15829550
J Infect Dis. 2015 Oct 1;212(7):1160-71
pubmed: 25805753
Circulation. 2017 Apr 18;135(16):1522-1531
pubmed: 28416524
Diabetologia. 2006 Oct;49(10):2281-90
pubmed: 16955208
Clin Chem Lab Med. 2014 Oct;52(10):1413-23
pubmed: 24940712
Diabetes Care. 2014 Oct;37(10):2843-63
pubmed: 25114297
Atherosclerosis. 2011 Jul;217(1):227-33
pubmed: 21481392
Lancet. 2018 Aug 11;392(10146):477-486
pubmed: 30129464
Lancet. 2012 Mar 31;379(9822):1214-24
pubmed: 22421340
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
J Diabetes Complications. 2018 Mar;32(3):325-329
pubmed: 29395841
Diabetologia. 1989 Feb;32(2):79-83
pubmed: 2721842
Eur J Prev Cardiol. 2014 Nov;21(11):1358-64
pubmed: 23847184
Diabetologia. 2005 Feb;48(2):370-8
pubmed: 15692810
Clin Cardiol. 2008 Feb;31(2):67-71
pubmed: 18257021
Biochim Biophys Acta. 2006 Apr;1760(4):616-35
pubmed: 16478649
J Am Coll Cardiol. 2012 Oct 2;60(14):1249-56
pubmed: 22939561

Auteurs

Maryam Saeed (M)

Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway maryam.saeed@medisin.uio.no.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

German Tapia (G)

Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.

Inger Ariansen (I)

Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.

Lars C Stene (LC)

Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.

Ingebjørg Seljeflot (I)

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Cardiology, Center for Clinical Heart Research, Oslo University Hospital, Oslo, Norway.

Grethe S Tell (GS)

Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Torild Skrivarhaug (T)

Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Geir Joner (G)

Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH